| Period | Price | Change | Percent Change |
|---|---|---|---|
| 1 week | $22.90 | +$0.19 | +0.83% |
| 1 month | $20.31 | +$2.78 | +13.69% |
| 3 months | $20.44 | +$2.65 | +12.96% |
| 6 months | $14.23 | +$8.86 | +62.26% |
| 1 year | $13.50 | +$9.59 | +71.04% |
| Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-11 | 42,653.89 | 11,237.58 | 242.07 | 1.8 | n/a | n/a | n/a | 0.0% |
| 31-Dec-12 | 51,391.48 | 12,570.41 | 276.69 | 1.9 | 0.1 | +14% | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Update on Pharmstandard buy-back program | 07-May-2013 | 11:15 | RNS |
| 2012FYResults/1Q2013TradeUpdate | 29-Apr-2013 | 08:00 | RNS |
| Notice of 2012FYResults/1Q2013TradeUpdate | 24-Apr-2013 | 10:40 | RNS |
No recent information was found.
No deals were found in the last 28 days.
| Currency | US Dollars |
| Price | $ 23.09 |
| Change Today | $ 0.49 |
| % Change | 2.17 % |
| 52 Week High | $23.32 |
| 52 Week Low | $22.60 |
| Volume | 58,732 |
| Shares Issued | 151.17m |
| Market Cap | $3,490.52m |
| RiskGrade | 126 |
| No dividends found |
| Time | Volume / Share Price |
| 16:45 | 800 @ $22.69 |
| 16:41 | 872 @ $22.85 |
| 16:38 | 2,747 @ $22.96 |
| 16:26 | 1,360 @ $22.87 |
| 16:04 | 1,413 @ $22.87 |
| Chair | Viktor Kharitonin |
You are here: research